Carvedilol Tablet, Film Coated
Product Images NDC 70518-0426

10 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 70518-0426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Carvedilol 6.25mg 70518 0426 01)

Mm2 (Carvedilol  6.25mg 70518 0426 01)
Label for Carvedilol 6.25 mg film-coated tablets, package quantity 180, repackaged by RemedyRepack Inc. The label shows the NDC number 70518-0426-01, manufacturing by Zydus Pharm in Pennington, NJ, with storage instructions and a barcode and QR code present.*
FDA Label Image

Carvedilol 6.25mg 70518 0426 02

Carvedilol  6.25mg 70518 0426 02
Carvedilol 6.25 mg film-coated tablets packaging label shows a quantity of 60 tablets. Label includes the NDC number 70518-0426-02 and states the manufacturer as Zydus Pharm, Pennington, NJ. The label advises storage at 20-25°C with permitted excursions and references the package insert for directions for use. Repackaged by RemedyRepack Inc., Indiana, PA.*
FDA Label Image

Carvedilol 6.25mg 70518 0426 03

Carvedilol  6.25mg 70518 0426 03
Carvedilol 6.25 mg film-coated tablets label showing quantity of 30 tablets. The label includes prescription-only status, NDC 70518-0426-03, manufacturer information (Zydus Pharm, Pennington, NJ), storage instructions, and repackager details (RemedyRepack Inc., Indiana, PA).*
FDA Label Image

Carvedilol 6.25mg 70518 0426 04

Carvedilol  6.25mg 70518 0426 04
Label for Carvedilol 6.25 mg film coated tablets, quantity of 90, repackaged by RemedyRepack Inc. Includes barcode, RX only designation, NDC number 70518-0426-04, manufacturer listed as Zydus Pharm, Pennington, NJ, and storage instructions. Contains a QR code and advises keeping medication out of reach of children.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Carvedilol 6.25 mg film-coated tablet label showing quantity of 30 tablets. The label includes the NDC 70518-0426-00, manufacturer information as Zydus Pharm, Pennington, NJ, and repackaging by RemedyRepack Inc. Safety and storage instructions are also present.*
FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 01

B1fa8af3 9789 45d2 8b77 A53935c52b49 01
Chemical structure of the active ingredient Carvedilol, showing its molecular framework with labeled functional groups and aromatic rings.*
FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 02

B1fa8af3 9789 45d2 8b77 A53935c52b49 02
A line graph comparing percentage mortality over 21 months between Carvedilol and placebo groups. The vertical axis shows % mortality, and the horizontal axis shows time in months. The graph indicates lower mortality for Carvedilol over time compared to placebo, with a reported P-value of 0.0014.*
FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 03

B1fa8af3 9789 45d2 8b77 A53935c52b49 03
A forest plot showing hazard ratios with 95% confidence intervals across various patient subgroups including gender, age, race, diabetic status, ischemic status, heart rate, systolic blood pressure, and spironolactone use, culminating in an overall estimate for all patients. Hazard ratios range from 0.0 to 2.0 on the x-axis.*
FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 04

B1fa8af3 9789 45d2 8b77 A53935c52b49 04
A line graph comparing percent mortality over 24 months between two groups: one treated with Carvedilol and a placebo group. The graph shows mortality increasing over time in both groups, with the Carvedilol group consistently having a lower percentage of mortality compared to placebo. Statistical significance is indicated by P = 0.03.*
FDA Label Image

B1fa8af3 9789 45d2 8b77 A53935c52b49 05

B1fa8af3 9789 45d2 8b77 A53935c52b49 05
A figure showing two hazard ratio forest plots comparing variables like age, sex, prior medication use, clinical conditions, and vital signs in relation to heart failure (CHF) risk and myocardial infarction (MI) outcomes. Each variable is depicted with hazard ratios and confidence intervals plotted along a similar horizontal axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.